Related Experiment Video
Updated: Aug 5, 2025

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer
Amy J Tibbo1,2, Andrew Hartley1,2, Richa Vasan1,2
1School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G61 1QH, UK.
Background:
Prostate cancer is the most common cancer in men in the developed world, with most deaths caused by advanced and metastatic disease which has no curative options. Here, we identified Mbtps2 alteration to be associated with metastatic disease in an unbiased in vivo screen and demonstrated its regulation of fatty acid and cholesterol metabolism.
Methods:
The Sleeping Beauty transposon system was used to randomly alter gene expression in the PtenNull murine prostate. MBTPS2 was knocked down by siRNA in LNCaP, DU145 and PC3 cell lines, which were then phenotypically investigated. RNA-Seq was performed on LNCaP cells lacking MBTPS2, and pathways validated by qPCR. Cholesterol metabolism was investigated by Filipin III staining.
Results:
Mbtps2 was identified in our transposon-mediated in vivo screen to be associated with metastatic prostate cancer. Silencing of MBTPS2 expression in LNCaP, DU145 and PC3 human prostate cancer cells reduced proliferation and colony forming growth in vitro. Knockdown of MBTPS2 expression in LNCaP cells impaired cholesterol synthesis and uptake along with reduced expression of key regulators of fatty acid synthesis, namely FASN and ACACA.
Conclusion:
MBTPS2 is implicated in progressive prostate cancer and may mechanistically involve its effects on fatty acid and cholesterol metabolism.
Insights
MBTPS2 alteration is linked to metastatic prostate cancer. Its silencing impairs cancer cell growth and affects fatty acid and cholesterol metabolism, offering potential therapeutic targets for advanced disease.
Area of Science:
- Oncology
- Molecular Biology
- Metabolism
Background:
- Prostate cancer is a leading cause of cancer death in men, primarily due to advanced and metastatic disease.
- Current treatments lack curative options for metastatic prostate cancer.
- Identifying novel molecular drivers of metastasis is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of MBTPS2 (Membrane Bound Transcription Factor Peptidase, Site 2) in prostate cancer progression and metastasis.
- To elucidate the functional impact of MBTPS2 alterations on cellular metabolism, specifically fatty acid and cholesterol pathways.
Main Methods:
- Utilized a Sleeping Beauty transposon system for unbiased in vivo genetic screening in a murine prostate cancer model.
- Performed MBTPS2 knockdown using siRNA in human prostate cancer cell lines (LNCaP, DU145, PC3).
- Conducted RNA-sequencing (RNA-Seq) and quantitative PCR (qPCR) to analyze gene expression changes and validated metabolic pathways. Employed Filipin III staining to assess cholesterol metabolism.
Main Results:
- MBTPS2 was identified as a gene associated with metastatic prostate cancer through in vivo screening.
- MBTPS2 knockdown significantly reduced proliferation and colony formation in human prostate cancer cells.
- Silencing MBTPS2 impaired cholesterol synthesis and uptake, and reduced the expression of fatty acid synthesis regulators (FASN, ACACA) in LNCaP cells.
Conclusions:
- MBTPS2 plays a significant role in the progression of prostate cancer.
- MBTPS2's involvement in metastatic prostate cancer may be mechanistically linked to its regulation of fatty acid and cholesterol metabolism.
- Targeting MBTPS2 could represent a novel therapeutic strategy for managing advanced prostate cancer.
More Related Videos
07:34Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Regulation of Nuclear Protein Sorting
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators
Abnormal Proliferation
Cholesterol: Significance and Regulation
Considering cholesterol and...